Advertisement
Visit TheBody.com for Patient Education
You are not currently logged in.
Login
or
Register
Sign up for free e-mail/fax newsletters!
E-Mail
Share
FDA-Approved Antiretrovirals
Antiretrovirals Overview
Multi-Class Combinations
Efavirenz/
Tenofovir/FTC (Atripla)
Entry Inhibitors (Fusion, CCR5, etc.)
Enfuvirtide (T-20, Fuzeon)
Maraviroc (Selzentry, Celsentri)
Integrase Inhibitors
Raltegravir (MK-0518, Isentress)
Protease Inhibitors
Atazanavir (Reyataz)
Darunavir (TMC114, Prezista)
Fosamprenavir (Lexiva, Telzir)
Indinavir (Crixivan)
Lopinavir/Ritonavir (Kaletra)
Nelfinavir (Viracept)
Ritonavir (Norvir)
Saquinavir (Invirase)
Tipranavir (Aptivus)
Nucleoside/Nucleotide Reverse Transcriptase Inhibitors
Abacavir (Ziagen)
Abacavir/Lamivudine (Epzicom, Kivexa)
Didanosine (ddI, Videx)
Emtricitabine (FTC, Emtriva)
Lamivudine (3TC, Epivir)
Stavudine (d4T, Zerit)
Tenofovir (Viread)
Tenofovir/Emtricitabine (Truvada)
Zalcitabine (ddC, Hivid)
Zidovudine (AZT, Retrovir)
Zidovudine/Lamivudine (Combivir)
Zidovudine/Lamivudine/
Abacavir (Trizivir)
Non-Nucleoside Reverse Transcriptase Inhibitors
Delavirdine (Rescriptor)
Efavirenz (Sustiva, Stocrin)
Etravirine (TMC125, Intelence)
Nevirapine (Viramune)
Antiretrovirals in Development
E-Mail
Share
Aging With Complex Chronic Disease: The Wrinkled Face of AIDS
Showing Sero-Different Couples Some Respect
AIDS 2010 Roundup: Men Who Have Sex With Men (MSM)
HIV and Inflammation: A New Threat
Raltegravir Lovefest, Vienna Edition: AIDS 2010 Studies Explore Various Strategies for Use -- A Blog Entry by Myles Helfand
More >>
Advertisement